Brief: VBL Therapeutics Announces Appointment Of Sam Backenroth As CFO And Establishes Operations In The United States

NeuBase Therapeutics

05/10/2021 13:13

Oct 5 (Reuters) - Vascular Biogenics Ltd  VBLT.O :
    * VBL THERAPEUTICS ANNOUNCES APPOINTMENT OF SAM BACKENROTH
AS
CHIEF FINANCIAL OFFICER AND ESTABLISHES OPERATIONS IN THE UNITED
STATES
    * VBL THERAPEUTICS ANNOUNCES APPOINTMENT OF SAM BACKENROTH
AS
CHIEF FINANCIAL OFFICER AND ESTABLISHES OPERATIONS IN THE UNITED
STATES
    * VBL THERAPEUTICS - MOST RECENTLY, BACKENROTH WAS CHIEF
FINANCIAL
OFFICER AT NEUBASE THERAPEUTICS

Source text for Eikon:  ID:nGNX7djJtq 
Further company coverage:  VBLT.O 

 ((Reuters.Briefs@thomsonreuters.com;))